Top 10 Stocks Under $10 That Could Triple
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Kura Oncology Inc. (KURA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 8,116,000 | $46,829,320 | +10% | 1.41% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 7,754,129 | $44,741,324 | 1.6% | |
| 3. | Armistice Capital Steven Boyd | 6,200,000 | $35,774,000 | -6% | 0.62% |
| 4. | EcoR1 Capital Oleg Nodelman | 4,200,000 | $24,234,000 | +60% | 1.43% |
| 5. | Prosight Capital Lawrence Hawkins | 3,181,184 | $18,355,432 | +54% | 4.48% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.20 | 50,000 | $410,145.00 | 100,968 | 2025-09-08 | Filing | |
| $6.64 | 13,494 | $89,623.10 | 50,968 | 2025-08-13 | Filing | |
| $5.85 | 36,506 | $213,578.35 | 37,474 | 2025-08-12 | Filing | |
| $11.50 | 50,000 | $575,000.00 | 139,557 | 2023-06-16 | Filing | |
| $13.16 | 83,540 | $1,099,386.40 | 4,408,097 | 2018-12-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.94 | 8,891 | $79,505.10 | 99,676 | 2025-09-29 | Filing | |
| $8.94 | 8,805 | $78,736.07 | 148,043 | 2025-09-29 | Filing | |
| $8.94 | 6,892 | $61,629.64 | 63,375 | 2025-09-29 | Filing | |
| $8.94 | 12,314 | $110,114.25 | 158,439 | 2025-09-29 | Filing | |
| $8.94 | 36,615 | $327,418.65 | 246,853 | 2025-09-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,265,030 | $11,195,516 | 0.02% | |
| 2. | 67,146 | $594,242 | 0.04% | |
| 3. | 14,900 | $131,865 | 0.02% | |
| 4. | 14,656 | $129,706 | 0% | |
| 5. | 12,196 | $107,935 | 0% |
News See All
Kura Oncology, Inc. (NASDAQ:KURA) Q2 2025 Earnings Call Transcript
Operator: Hello, and welcome, everyone, joining today's Second Quarter 2025 Kura Oncology, Inc. Financial Results Conference Call. [Operator Instructions] Please note this call is being recorded.
FDA Grants Priority Review for Kura Oncology, Inc. (KURA) and Kyowa Kirin’s Ziftomenib
The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ziftomenib, an investigational treatment pursued by Kura Oncology, Inc.
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2025 Earnings Call Transcript
Operator: Good day everyone and welcome to today’s First Quarter 2025 Kura Oncology Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's Q4 2024 Kura Oncology, Inc. Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide.
Kura Oncology, Inc. (NASDAQ:KURA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Kura Oncology Third Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.